|1.||Lehert, P: 7 articles (01/2009 - 07/2000)|
|2.||Mosnier, M: 3 articles (06/2001 - 07/2000)|
|3.||Harnan, S: 2 articles (12/2012 - 12/2011)|
|4.||Meng, Y: 2 articles (12/2012 - 12/2011)|
|5.||Stansby, G: 2 articles (12/2012 - 12/2011)|
|6.||Thomas, S: 2 articles (12/2012 - 12/2011)|
|7.||Squires, H: 2 articles (12/2012 - 12/2011)|
|8.||Michaels, J: 2 articles (12/2012 - 12/2011)|
|9.||Simpson, E: 2 articles (12/2012 - 12/2011)|
|10.||Hossain, Murad: 2 articles (05/2012 - 08/2009)|
03/01/2001 - "This study demonstrated the efficacy of naftidrofuryl versus placebo in patients with intermittent claudication with a highly significant and clinically relevant difference and confirmed its good safety profile."
04/01/2001 - "This study demonstrates the efficacy of naftidrofuryl versus placebo in patients with intermittent claudication using a new device measuring the walking distances of the patients in a more physiological way than the treadmill test."
03/01/2001 - "A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. "
01/01/2009 - "To assess the efficacy of naftidrofuryl compared with placebo in treating the symptoms of intermittent claudication. "
03/01/2002 - "We report in this paper the findings of a pooled analysis of 3 previously published studies undertaken in Germany, France and Belgium to assess the effects of naftidrofuryl on the quality of life of patients with intermittent claudication. "
07/01/1989 - "Ischemia-induced changes in brain levels of monoamines and their metabolites of mice and rats: some protective effects of naftidrofuryl."
01/01/1987 - "Severe stages of ischemia, evaluated as described by Fagrell, were improved by naftidrofuryl treatment. "
03/01/2001 - "Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS)."
11/01/1993 - "The present study was designed to elucidate the possible beneficial effects of naftidrofuryl on ischemia-induced endothelium damage. "
11/01/1994 - "[Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. "
|3.||Arterial Occlusive Diseases (Arterial Occlusive Disease)
03/01/1988 - "In a randomized, double-blind, placebo-controlled study in patients with peripheral arterial occlusive disease stage IIb of Fontaine's classification, the efficacy of naftidrofuryl, a vasoactive substance, was investigated. "
01/01/1988 - "[Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease]."
01/01/1988 - "[Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease]."
01/01/1988 - "[Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease]."
11/01/1984 - "The results indicate that naftidrofuryl has a beneficial effect on the symptoms and lengthens the painfree walking distance in patients with arterial occlusive disease."
05/01/1980 - "Although both groups significantly increased their walking time to the onset of pain, those patients over 60 years old taking naftidrofuryl showed a significant improvement over their pretreatment walking times to onset of pain, whereas their controls did not."
04/01/1981 - "Praxilene produced subjective improvement in the symptoms of rest pain in 5 patients out of 16 in this small study."
11/01/1994 - "This study demonstrates the benefit of naftidrofuryl in pain reduction which was assessed, in particular, by the reduction of analgesic consumption."
04/01/1981 - "Naftidrofuryl for ischaemic rest pain: a controlled trial."
01/01/2012 - "Treatment with naftidrofuryl tended to show reduction of pain evaluated by both analogue score and analgesic consumption, but the effect was statistically non-significant (mean difference (MD): 0.42; 95% confidence interval (CI)1.19 to 0.35). "
07/01/2000 - "This study examined the efficacy of naftidrofuryl in patients with vascular or mixed dementia. "
07/01/2000 - "Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial."
10/01/2000 - "The efficacy of naftidrofuryl in patients with vascular or mixed dementia."
01/01/2011 - "Randomised placebo-controlled trials in which patients with dementia were treated with naftidrofuryl were considered eligible for inclusion. "
07/01/2000 - "The results of this study suggest that naftidrofuryl is effective and well tolerated in treating the symptoms of vascular and mixed dementia."
|7.||Serotonin (5 Hydroxytryptamine)